Cargando…

Pioglitazone, bladder cancer, and detection bias

Detalles Bibliográficos
Autor principal:	Dolin, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2014
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282397/ https://www.ncbi.nlm.nih.gov/pubmed/24004505 http://dx.doi.org/10.1111/1753-0407.12087

Ejemplares similares

Pioglitazone as a novel therapeutic approach in chronic granulomatous disease
por: Migliavacca, Maddalena, et al.
Publicado: (2016)

Evaluation of exposure to pioglitazone and risk of prostate cancer: a nested case–control study
por: Boxall, Naomi, et al.
Publicado: (2016)

Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries
por: Korhonen, Pasi, et al.
Publicado: (2016)

Letter: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
por: Li, Sheyu, et al.
Publicado: (2013)

Letter: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
por: Kim, Sang-Yong
Publicado: (2012)

Pioglitazone Use and Risk of Bladder Cancer: an In Vitro Study
por: Yang, Shao-ling, et al.
Publicado: (2018)

Pioglitazone and the Risk of Bladder Cancer: A Meta-Analysis
por: Filipova, Elena, et al.
Publicado: (2017)

Aspirin potentiates blood glucose lowering effect of glimepiride-pioglitazone combination in streptozotocin-induced diabetic rats
por: Bag, Soumita, et al.
Publicado: (2014)

Post-treatment with the PPAR-γ agonist pioglitazone inhibits inflammation and bacterial growth during Klebsiella pneumonia
por: Ramirez-Moral, Ivan, et al.
Publicado: (2021)

Re: “Multiparametric cystoscopy: opportunities to enhance bladder cancer detection”
por: Kriegmair, Maximilian Christian, et al.
Publicado: (2020)

Pioglitazone and Bladder Cancer: A population-based study of Taiwanese
por: Tseng, Chin-Hsiao
Publicado: (2012)

The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
por: Song, Sun Ok, et al.
Publicado: (2012)

Pioglitazone and the risk of bladder cancer: An Indian retrospective cohort study
por: Gupta, Sunil, et al.
Publicado: (2015)

Correlation between changes in blood pressure with insulin resistance in type 2 diabetes mellitus with four weeks of pioglitazone therapy
por: Dash, Sandip Kumar
Publicado: (2008)

Comment on “Bladder Cancer–Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection”
por: Güllü Amuran, Gökçe
Publicado: (2019)

Pioglitazone use and risk of bladder cancer: population based cohort study
por: Tuccori, Marco, et al.
Publicado: (2016)

Pioglitazone and bladder cancer risk: a systematic review and meta‐analysis
por: Tang, Huilin, et al.
Publicado: (2018)

Pioglitazone-Induced Acute Rhabdomyolysis
por: Slim, Raoudha, et al.
Publicado: (2009)

Sleep duration and breast cancer risk in the breast cancer detection demonstration project follow-up cohort: true associations or bias?
por: Yang, W-S, et al.
Publicado: (2015)

Correction of ‘Bias factor, maximum bias and the E-value’
por: Sjölander, Arvid, et al.
Publicado: (2021)

Reply to ‘Sleep duration and breast cancer risk in the breast cancer detection demonstration project follow-up cohort: true associations or bias?'
por: Qian, X, et al.
Publicado: (2015)

Bias, the unfinished symphony
por: Coşkun, Abdurrahman
Publicado: (2022)

Pulse oximetry, racial bias and statistical bias: further improvements of pulse oximetry are necessary
por: Ferrari, Marco, et al.
Publicado: (2022)

Biased Goiter Prevalence Estimate
por: Soudarssanane, MB, et al.
Publicado: (2009)

Misclassification bias and unnecessary anxiety
por: Knight, Marian, et al.
Publicado: (2021)

A retrospective study on finding correlation of pioglitazone and incidences of bladder cancer in the Indian population
por: Balaji, V., et al.
Publicado: (2014)

Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting
por: Piccinni, Carlo, et al.
Publicado: (2011)

Global and Regional Effects of Bladder Cancer Risk Associated with Pioglitazone Therapy in Patients with Diabetes
por: Qu, Hua, et al.
Publicado: (2017)

A descriptive study of occupation and bladder cancer in England and Wales.
por: Dolin, P. J.
Publicado: (1992)

First Case of Cellular Cannibalism in Small-Cell Carcinoma of the Bladder Detected in Peripheral Blood
por: Kang, Hyein, et al.
Publicado: (2019)

Pioglitazone Induces Dysplastic Urothelial Changes in Urinary Bladder of Experimental Diabetes
por: Abdel-Hamid, Ahmed A. M., et al.
Publicado: (2021)

Intravesical therapy for bladder cancer in the pandemic of Covid-19
por: Teoh, Jeremy Y. C., et al.
Publicado: (2020)

Bladder Preservation with Primary Closure in an Adolescent Girl with Bladder Exstrophy
por: Aslan, Yılmaz, et al.
Publicado: (2017)

Censoring in survival analysis: Potential for bias
por: Ranganathan, Priya, et al.
Publicado: (2012)

Misclassification and Bias in Military Studies of Mefloquine
por: Lee Nevin, Remington
Publicado: (2017)

Reference bias in the Illumina Isaac aligner
por: Cornish, Alex J, et al.
Publicado: (2020)

Unconscious gender bias in academic publications
por: Kearsley, Rosemarie
Publicado: (2021)

Ectopic prostate tissue at the bladder trigone accompanied by cystitis glandularis and hemorrhage detected by multiparametric MRI
por: Sun, Meng-Ya, et al.
Publicado: (2022)

Impact of urinary bladder cancer risk variants on prognosis and survival
por: Selinski, Silvia
Publicado: (2014)

Does age really matter in the choice of treatment for bladder cancer?
por: Dal Moro, F, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ksl8gu94g6e3q02mvhnjjec9qp